(NASDAQ: INGN) Inogen's forecast annual revenue growth rate of 7.92% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.2%.
Inogen's revenue in 2026 is $348,668,000.On average, 4 Wall Street analysts forecast INGN's revenue for 2026 to be $10,246,988,658, with the lowest INGN revenue forecast at $9,837,141,791, and the highest INGN revenue forecast at $10,556,892,801.
In 2027, INGN is forecast to generate $11,052,521,571 in revenue, with the lowest revenue forecast at $10,386,962,937 and the highest revenue forecast at $11,626,307,186.